Latest KFF Health News Stories
Programa forma médicos multiculturales, pero no siempre ejercen en áreas vulnerables
Investigadores han descubierto que el programa ha logrado diversificar la inscripción, pero no hay suficiente seguimiento a largo plazo para saber si estos graduados ejercen en las regiones donde más se necesitan.
Disability Rights Groups Sue to Overturn California’s Physician-Assisted Death Law
Disability rights advocates and two individuals with disabilities sued Tuesday to overturn the state’s physician-assisted death law, arguing it is unconstitutional, violates the Americans with Disabilities Act, and makes it too easy for people with terminal diseases whose deaths aren’t imminent to kill themselves with a doctor’s help.
Presentan demanda para revocar ley de muerte asistida en California
La ley original de California, que permite a los adultos con enfermedades terminales obtener recetas para medicamentos que pongan fin a su vida, se aprobó en 2016.
Depressed? Anxious? Air Pollution May Be a Factor
A growing body of research is finding links between air quality and mental health, as therapists report seeing patients with symptoms linked to pollution.
A California Physician Training Program Adds Diversity, but Where Do Graduates End Up?
Researchers found that, while a University of California medical training program has diversified the system’s pool of medical students, there’s not enough long-term data to know whether graduates return to practice where they’re needed most.
El dolor, la esperanza y la ciencia chocan cuando los atletas recurren a los hongos mágicos
El uso de hongos psicodélicos está ganando terreno en los Estados Unidos. Investigadores predicen que la FDA aprobará un tratamiento psicodélico en los próximos cinco años.
¿Se podrá cumplir con la meta de terminar con la epidemia de VIH para 2030?
Debido a las interrupciones de la pandemia, los funcionarios federales no han tenido estimaciones sólidas de nuevas infecciones o el número de personas que viven con VIH desde finales de 2019.
US Officials Want to End the HIV Epidemic by 2030. Many Stakeholders Think They Won’t.
The federal government’s ambitious plan to end the HIV epidemic, launched in 2019, has generated new ways to reach at-risk populations in targeted communities across the South. But health officials, advocates, and people living with HIV worry significant headwinds will keep the program from reaching its goals.
Pain, Hope, and Science Collide as Athletes Turn to Magic Mushrooms
A group of former professional athletes traveled to Jamaica to try psychedelics as a way to help cope with the aftereffects of concussions and a career of body-pounding injuries. Will this still largely untested treatment work?
The Biden Administration Vowed to Be a Leading Voice on Opioid Settlements But Has Gone Quiet
Billions of dollars are headed to state and local governments to address the opioid crisis. Policy experts and advocates expect the federal government to play a role in overseeing the use of the money. Failure to do so, they say, could lead to wasted opportunities. And, since Medicaid helps pay health care costs, the feds could have a claim to portions of states’ opioid settlements.
Tension Builds in Transgender Policy Debate in Montana
Two transgender lawmakers are trying to lay the groundwork for LGBTQ-friendly policies in a conservative state, but tensions are running high as the legislative session nears its end.
Lose Weight, Gain Huge Debt: NY Provider Has Sued More Than 300 Patients Who Had Bariatric Surgery
The private equity-backed practice has been known to demand more than $100,000 in charges or penalties. One patient is fighting back.
An Arm and a Leg: A $229,000 Medical Bill Goes to Court
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court’s ruling could have major implications for determining a “reasonable price” in health care.
California’s Medicaid Experiment Spends Money to Save Money — And Help the Homeless
Gov. Gavin Newsom’s ambitious experiment in health care is supposed to cut costs as it fills the needs of hard-to-reach people. The program’s start is chaotic and limited, but it shows promise.
Con el fin de la emergencia sanitaria, personas con covid de largo plazo se sienten abandonadas
A un paso del fin de la emergencia nacional de salud pública en mayo, muchas personas con síntomas prolongados de covid se sienten abandonadas por legisladores que están ansiosos por dar vuelta la página.
As Pandemic Emergencies End, People Battling Long Covid Feel ‘Swept Under the Rug’
Millions of Americans suffer from long covid, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel they’re on their own.
People With Down Syndrome Are Living Longer, but the Health System Still Treats Many as Kids
The median life expectancy for a U.S. baby born with Down syndrome jumped from about four years in 1950 to 58 years in the 2010s. That’s largely because they no longer can be denied lifesaving care, including surgeries for heart defects. But now, aging adults with Down syndrome face a health system unprepared to care for them.
Journalists Track Opioid Settlement Cash and Fees for Telehealth Visits
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
A Smart Move on Tax Day: Get Health Insurance Information Using Your State’s Tax Forms
A growing number of states — including Maryland, Colorado, and Massachusetts — are using tax forms to point people toward lower-cost health coverage available through state insurance marketplaces.
KFF Health News' 'What the Health?': The Confusing Fate of the Abortion Pill
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
